Please login to the form below
Longitude Prize
This page shows the latest Longitude Prize news and features for those working in and with pharma, biotech and healthcare.
Longitude Prize awards grants for antibiotic test development
Daniel Berman, Longitude Prize lead at UK innovation foundation Nesta, said: “The groups receiving these grants are working across a range of technologies, from nanosensors to gene detectors to lasers, but ... Launched by David Cameron at the G8 Summit
Latest news
-
NICE wants responsible use of antibiotics in pneumonia
The need to improve diagnostic efforts in bacterial infections was highlighted earlier this year in the winner of the Longitude Prize, a UK innovation prize that was awarded to the development
-
Antibiotics: pharma's Cinderella story
In the UK the Longitude Prize awarded for addressing societal challenges was this year granted to the development of rapid, reliable point of care diagnostics to enable more effective use of
-
UK healthcare professionals urged to say 'no' to antibiotics
The urgent need to revise the way the antibiotics are used also led to the £10m Longitude Prize being awarded to a diagnostic tool for bacterial infections, while a campaign to
-
Pharma industry backs UK antibiotics plan
The launch of the review follows the announcement this week that the Longitude Prize will focus on antibiotics.
-
UK innovation prize to support antibiotic diagnostics
The Longitude Prize, which was launched by Prime Minister David Cameron at G8 last year, is looking to support research into a simple test to determine if an infection is caused ... The Longitude Prize chose to invest in antibiotic research after the
NICE wants responsible use of antibiotics in pneumonia
UK healthcare professionals urged to say 'no' to antibiotics
UK innovation prize to support antibiotic diagnostics
More from news
Approximately 2 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Tackling antimicrobial resistance on multiple fronts
Indeed, the innovations in the race to win the Longitude Prize, an £8m challenge prize to accelerate the development of a rapid, affordable point-of-care diagnostic test to reduce overuse ... The Longitude Prize. From a design perspective, we know that
-
The AMR threat
Dame Sally has worked hard to raise awareness of the challenges involved in tackling antibiotic resistance, and she helped bring it to a world stage via the innovative Longitude Prize. ... Launched at the 2013 G8 meeting, the prize supports research into
Tackling antimicrobial resistance on multiple fronts
The AMR threat
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Antibiotic Resistance: Alarm bells ring louder than ever
Plus, recent financial incentives have been encouraging these smaller players, as exemplified by the £10 million 2014 Longitude Prize. .
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Digital strategist
-
Competitive
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
-
Digital account director
-
Competitive
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- GSK reveals plans for £400m R&D facility expansion in England
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
- Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
